Name | Number of supported studies | Average coverage | |
---|---|---|---|
non-classical monocyte | 14 studies | 32% ± 10% | |
classical monocyte | 12 studies | 28% ± 7% | |
monocyte | 8 studies | 22% ± 4% |
Insufficient scRNA-seq data for expression of HK3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 5571.81 | 578 / 578 | 89% | 12.26 | 1026 / 1155 |
adrenal gland | 89% | 1061.05 | 229 / 258 | 50% | 2.78 | 116 / 230 |
bladder | 76% | 653.43 | 16 / 21 | 62% | 6.62 | 314 / 504 |
intestine | 69% | 526.73 | 665 / 966 | 62% | 4.80 | 328 / 527 |
breast | 63% | 544.36 | 289 / 459 | 62% | 4.66 | 697 / 1118 |
kidney | 45% | 345.17 | 40 / 89 | 73% | 4.78 | 658 / 901 |
thymus | 46% | 241.45 | 299 / 653 | 66% | 4.20 | 401 / 605 |
liver | 67% | 730.71 | 152 / 226 | 41% | 2.50 | 168 / 406 |
uterus | 36% | 212.20 | 62 / 170 | 71% | 5.56 | 325 / 459 |
stomach | 41% | 359.53 | 148 / 359 | 63% | 4.05 | 180 / 286 |
spleen | 100% | 17167.95 | 241 / 241 | 0% | 0 | 0 / 0 |
esophagus | 49% | 377.71 | 705 / 1445 | 48% | 2.52 | 88 / 183 |
lymph node | 0% | 0 | 0 / 0 | 97% | 41.03 | 28 / 29 |
pancreas | 14% | 80.25 | 46 / 328 | 81% | 8.62 | 144 / 178 |
adipose | 94% | 1468.36 | 1128 / 1204 | 0% | 0 | 0 / 0 |
ovary | 29% | 156.57 | 52 / 180 | 59% | 2.90 | 252 / 430 |
skin | 6% | 29.28 | 115 / 1809 | 78% | 8.36 | 368 / 472 |
peripheral blood | 84% | 33063.16 | 777 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 80% | 8.96 | 36 / 45 |
heart | 65% | 530.56 | 559 / 861 | 0% | 0 | 0 / 0 |
brain | 4% | 19.34 | 115 / 2642 | 44% | 3.72 | 310 / 705 |
prostate | 32% | 210.69 | 79 / 245 | 16% | 0.52 | 78 / 502 |
blood vessel | 44% | 423.31 | 591 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 15% | 0.66 | 12 / 80 |
muscle | 11% | 45.58 | 88 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006002 | Biological process | fructose 6-phosphate metabolic process |
GO_0046835 | Biological process | carbohydrate phosphorylation |
GO_0061621 | Biological process | canonical glycolysis |
GO_0051156 | Biological process | glucose 6-phosphate metabolic process |
GO_0001678 | Biological process | intracellular glucose homeostasis |
GO_0006096 | Biological process | glycolytic process |
GO_0006006 | Biological process | glucose metabolic process |
GO_0034774 | Cellular component | secretory granule lumen |
GO_1904813 | Cellular component | ficolin-1-rich granule lumen |
GO_0005739 | Cellular component | mitochondrion |
GO_0005829 | Cellular component | cytosol |
GO_0005576 | Cellular component | extracellular region |
GO_0004396 | Molecular function | hexokinase activity |
GO_0005536 | Molecular function | D-glucose binding |
GO_0005515 | Molecular function | protein binding |
GO_0005524 | Molecular function | ATP binding |
GO_0008865 | Molecular function | fructokinase activity |
GO_0004340 | Molecular function | glucokinase activity |
Gene name | HK3 |
Protein name | Hexokinase III (EC 2.7.1.1) Hexokinase-3 (EC 2.7.1.1) (Hexokinase type III) (HK III) (Hexokinase-C) Phosphotransferase (EC 2.7.1.-) Hexokinase 3 |
Synonyms | |
Description | FUNCTION: Catalyzes the phosphorylation of hexose, such as D-glucose and D-fructose, to hexose 6-phosphate (D-glucose 6-phosphate and D-fructose 6-phosphate, respectively) . Mediates the initial step of glycolysis by catalyzing phosphorylation of D-glucose to D-glucose 6-phosphate . . |
Accessions | ENST00000504910.1 Q16779 ENST00000292432.10 H0Y9N6 P52790 ENST00000514058.1 ENST00000509717.5 H0YAG4 H0Y8U9 |